Search

Your search keyword '"Samantha Sartori"' showing total 443 results

Search Constraints

Start Over You searched for: Author "Samantha Sartori" Remove constraint Author: "Samantha Sartori"
443 results on '"Samantha Sartori"'

Search Results

1. Cerebrovascular Events in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Pooled Patient‐Level Study

2. Change in left ventricular function and outcomes following high-risk percutaneous coronary intervention with Impella-guided hemodynamic support

3. Outcomes Following Percutaneous Coronary Intervention in Patients With Multivessel Disease Who Were Recommended for But Declined Coronary Artery Bypass Graft Surgery

4. Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis

5. Impact of body mass index on outcomes in patients undergoing transfemoral transcatheter aortic valve implantationCentral MessagePerspective

6. 1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry

7. Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era

8. Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry

10. Determinants of Seattle Angina Questionnaire in Multivessel Disease Patients Undergoing Percutaneous Coronary Intervention: Insights from a Single-Center Study

11. Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation

12. Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease

13. Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery Disease

14. Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCI

15. Guided and unguided de-escalation from potent P2Y(12) inhibitors among patients with acute coronary syndrome

16. Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention

17. Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction

18. Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation

19. Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention

20. Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI

21. Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris

22. Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents

23. Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI

24. Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis

25. Supplementary Tables S1-S6 from Effect of Occupational Exposures on Lung Cancer Susceptibility: A Study of Gene–Environment Interaction Analysis

26. Data from Effect of Occupational Exposures on Lung Cancer Susceptibility: A Study of Gene–Environment Interaction Analysis

27. Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort

28. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of glassy and twilight

29. Ticagrelor with or without aspirin in high-risk patients with anemia undergoing percutaneous coronary intervention : a subgroup analysis of the TWILIGHT trial

31. Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis

32. 761 PRASUGREL OR CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AT DIFFERENT THROMBOTIC RISK: RESULTS FROM THE PROMETHEUS STUDY

33. Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study

34. Atrial Fibrillation in Patients Hospitalized With COVID-19

35. Types of myocardial injury and mid-term outcomes in patients with COVID-19

36. Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI

37. Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF

38. Not only how much, but also how to, when measuring epicardial adipose tissue

39. New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention

40. Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial

45. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI

46. One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration

47. Radial versus femoral access for coronary interventions: An updated systematic review and meta‐analysis of randomized trials

48. Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction

49. Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry

50. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent

Catalog

Books, media, physical & digital resources